Document is current
Any future updates will be listed below
-
Authors
Garland, Eric L.
Sullivan, Mark D.
-
Funding
Funding for this research was provided by:
National Institute on Drug Abuse (R01DA058621)
- License Information
-
More Information
Article History
Received: 27 January 2025
Accepted: 10 June 2025
First Online: 2 July 2025
Declarations:
:
: Eric Garland, PhD, is the Director of UCSD ONEMIND (Optimized Neuroscience-Enhanced Mindfulness Intervention Design). UCSD ONEMIND provides Mindfulness-Oriented Recovery Enhancement (MORE), mindfulness-based therapy, and cognitive behavioral therapy in the context of research trials for no cost to research participants; however, Dr. Garland has received honoraria and payment for delivering seminars, lectures, and teaching engagements (related to training clinicians in MORE), including those sponsored by institutions of higher education, government agencies, academic teaching hospitals, and medical centers. Dr. Garland also receives royalties from the sale of books related to MORE. Dr. Garland has also been a consultant and licensor to BehaVR, LLC.
: No other authors have any related conflicts of interest to disclose.
: The National Institutes of Health had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.
Free to read: This content has been made available to all.
